INDO-LEMMON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Indo-lemmon, and when can generic versions of Indo-lemmon launch?
Indo-lemmon is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in INDO-LEMMON is indomethacin. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Indo-lemmon
A generic version of INDO-LEMMON was approved as indomethacin by CHARTWELL MOLECULES on August 6th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INDO-LEMMON?
- What are the global sales for INDO-LEMMON?
- What is Average Wholesale Price for INDO-LEMMON?
Summary for INDO-LEMMON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 164 |
| Patent Applications: | 4,173 |
| DailyMed Link: | INDO-LEMMON at DailyMed |
US Patents and Regulatory Information for INDO-LEMMON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | INDO-LEMMON | indomethacin | CAPSULE;ORAL | 070266-001 | Nov 7, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | INDO-LEMMON | indomethacin | CAPSULE;ORAL | 070267-001 | Nov 7, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
